Loading...

EVOFEM BIOSCIENCES INC Earnings Reports 8-K Filing

VFM

EVOFEM BIOSCIENCES INC

()

2026 8-K

Distributorship Agreement

Securities Agreement Update

Agreement Termination

2025 Financial Results

Corporate Presentation Update

Annual Meeting Results

Financial Results Report

Merger Termination

Securities Purchase Amendment

Financial Results Report

Equity Offerings

Licensing Agreement

Financial Statements

Securities Agreement

License Agreement

Financial Results

External Links:

Evofem Biosciences, Inc. reported its financial results for the year ending December 31, 2025, via a press release on March 11, 2026. The filing includes information about anticipated COGS reduction initiatives and international market expansion.

AI Assistant

EVOFEM BIOSCIENCES INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.